Decellularized placental matrices for adipose tissue engineering.

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

• Level A · Stronger Clinical Evidence
• Level B · Emerging clinical evidence with positive signals
• Level C · Early human research exploring benefits
• Level D · Scientific groundwork from lab and animal studies
• Emerging · Emerging topic under active research

Abstract (original English)

A tissue-engineered adipose substitute would be invaluable to plastic surgeons for reconstructive, corrective, and cosmetic procedures. This work involves the design of a scaffold for soft tissue augmentation incorporating the decellularized extracellular matrix (ECM) of human placenta. We have developed a protocol to decellularize an intact, large segment (8 cm by 8 cm) of the human placenta. To facilitate the complete decellularization of the dense matrix, a system was designed to perfuse the required chemicals into the placenta via the existing vasculature. Following processing, the original architecture of the placental ECM was preserved, including an intact vascular network. Histological, immunohistochemical, and scanning electron microscopic analyses confirmed the removal of the cells and cellular debris and characterized the composition and structure of the matrix. In vitro cell culture experimentation showed that the placental decellular matrix (PDM) could facilitate the adhesion of primary human adipose precursor cells at early time points. The PDM has great potential for use as a scaffold for adipose tissue engineering, as the placenta is a rich source of human ECM components that can be readily harvested without harm to the donor.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.